No Data
Companies Like Silence Therapeutics (NASDAQ:SLN) Are In A Position To Invest In Growth
Buy Rating for Silence Therapeutics: Promising Phase 1 Results and Future Prospects
We're Hopeful That Silence Therapeutics (NASDAQ:SLN) Will Use Its Cash Wisely
Express News | Silence Therapeutics - From Time to Time, Co or Any Selling Shareholder May Offer and Sell Ordinary Shares
Express News | Silence Therapeutics PLC Files for Stock Shelf; Size Not Disclosed - SEC Filing
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading